本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Eledon Pharmaceuticals, Inc.

2.77
-0.0100-0.36%
成交量:52.08萬
成交額:144.87萬
市值:2.25億
市盈率:-2.81
高:2.88
開:2.88
低:2.75
收:2.78
52周最高:4.60
52周最低:1.35
股本:8,126.12萬
流通股本:7,456.71萬
量比:0.61
換手率:0.70%
股息:- -
股息率:- -
每股收益(TTM):-0.9867
每股收益(LYR):-0.5566
淨資產收益率:-110.71%
總資產收益率:-39.02%
市淨率:3.12
市盈率(LYR):-4.98

資料載入中...

2021/05/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/04/27

重要事件披露

8-K - Current report
2021/04/12

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/15

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/07

重要事件披露

8-K - Current report
2021/01/05

重要事件披露

8-K - Current report
2021/01/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/30

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/28

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/22

重要事件披露

8-K - Current report
2020/12/17

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/10

重要事件披露

8-K - Current report